Showing results (21-30 of 813) with videos related to
Sort By:
Pageof 82
Der Urologe. Ausg. A|February 20, 2014
[Squamous cell lesions of the urinary bladder]S Rausch, N Gaisa, R F Youssef, et al.Der Urologe. Ausg. A|September 8, 2017
[TKI 2.0 - changes in the medical treatment of renal cell carcinoma]V Stühler, S Kruck, M Hegemann, et al.World Journal of Urology|December 2, 2011
Prostatic peripheral nerve distribution may impact the functional outcome of nerve-sparing prostatectomyB Amend, J Hennenlotter, U Kuehs, et al.World Journal of Urology|August 13, 2015
Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancerS Kaufmann, J Bedke, S Gatidis, et al.Der Urologe. Ausg. A|March 12, 2014
[Cell-based therapy to treat stress urinary incontinence: which cell type at what cost?]M Vaegler, L A DaSilva, K Benz, et al.Der Urologe. Ausg. A|November 10, 2012
[New treatment strategies for male lower urinary tract symptoms]L F Arenas da Silva, M Schönthaler, F Cruz, et al.Der Urologe. Ausg. A|February 13, 2007
[Value of stem cell therapy for the treatment of stress incontinence. Current status and perspectives]K-D Sievert, B Amend, M Renninger, et al.BMC Urology|April 13, 2021
Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinomaWilhelm K Aicher, M Korn, L Reitnauer, et al.World Journal of Urology|September 20, 2011
Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?M Horstmann, L M Geiger, U Vogel, et al.Journal of Cancer Research and Clinical Oncology|September 9, 2025
Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomyM Maas, K Funk, V Stühler, et al.Pageof 82